Okasa Generics Private Limited - Company Profile

It is a chemicals private limited company based in Mumbai, Maharashtra, India, established in 2000.
2000 Mumbai, Maharashtra, India Struck Off
Last Updated:
Access Report
About Okasa Generics Private Limited

Okasa Generics Private Limited, a struck off private limited company, was established on 10 April 2000 in Mumbai, Maharashtra, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24234MH2000PTC125744. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Srinivas Hariharan (Director), Shankar Srinivasan (Director). Past directors included Ijaj Abdulgani Khalif, Raman Parameswaran Athipotta, Srinivas Hariharan. Its latest AGM occurred on 23 August 2017, with the balance sheet filed on 31 March 2017. It is based at 1St Floor, Hornby View Building 12, Rustom Sidhwa Marg, Mumbai, Maharashtra, 400001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24234MH2000PTC125744

  • Registration Number

    125744

  • Incorporation Date

    10 April 2000

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 25 Year, 10 Months
  • Last Filing with ROC 31 Mar 2017
Company report

Okasa Generics Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Okasa Generics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Okasa Generics Private Limited?
Current Directors
Name Designation Appointment Date Status
Srinivas Hariharan Director 23 Dec 2016 Current
Shankar Srinivasan Director 25 Aug 2015 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 25 Aug 2015 Past
Pramod Abcsdd Director 23 Dec 2016 Past
Pramod Abcsdd Additional Director 23 Aug 2017 Past
Pramod Abcsdd Additional Director 30 Sep 2015 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Okasa Generics.

Okasa Generics Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Okasa Generics revenue growth over time
Okasa Generics profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Okasa Generics?

In 2017, Okasa Generics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Okasa Generics?

Unlock and access historical data on people associated with Okasa Generics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Okasa Generics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Okasa Generics's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Okasa Generics
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Okasa Generics Private Limited last Annual general meeting of members was held on 23 Aug 2017 as per latest MCA records. was documented.

  • Balance Sheet

    Okasa Generics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2017 with Roc Mumbai. was recorded as a recent event.

  • Director Appointment

    Progress on Srinivas Hariharan was appointed as a Director was appointed as a Director on 23 Dec 2016 & has been associated with this company since 9 years 1 month . was documented.

  • Director Appointment

    Progress on Shankar Srinivasan was appointed as a Director was appointed as a Director on 25 Aug 2015 & has been associated with this company since 10 years 5 months . was documented.

  • Company Incorporation

    Progress on Okasa Generics Private Limited was registered on 10 Apr 2000 with Roc Mumbai & aged 25 years 10 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Okasa Generics Private Limited?

The CIN of Okasa Generics Private Limited is U24234MH2000PTC125744.

Where is Okasa Generics Private Limited headquartered?

Okasa Generics Private Limited is headquartered at 1St Floor, Hornby View Building 12, Rustom Sidhwa Marg, Mumbai, Maharashtra, 400001.

When was Okasa Generics Private Limited incorporated?

Okasa Generics Private Limited was incorporated on 10 April 2000.

Who are the current directors of Okasa Generics Private Limited?

The current directors of Okasa Generics Private Limited are

What is the primary industry of Okasa Generics Private Limited?

The primary industry of Okasa Generics Private Limited is Chemicals.

Is Okasa Generics Private Limited a listed company?

Okasa Generics Private Limited is unlisted.

What is the capital structure of Okasa Generics Private Limited?

The authorized capital of Okasa Generics Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available